Macular oedema: the measurements that count

Article

Thickness measurements of the central macular region can be used to differentiate between eyes with and without diffuse clinically significant macular oedema (CSMO), but not between eye with or without foveal CSMO, according to a study published in the February issue of Acta Ophthalmologica Scandinavia.

Thickness measurements of the central macular region can be used to differentiate between eyes with and without diffuse clinically significant macular oedema (CSMO), but not between eye with or without foveal CSMO, according to a study published in the February issue of Acta Ophthalmologica Scandinavia.

Lars Loumann Knudsen from the Aarhus University Hospital, Aalborg, Denmark, conducted a study that included 47 normal subjects and 158 ocular examinations of 38 eyes from 22 diabetic subjects with and without CSMO. The central macular region was subdivided into narrow concentric rings around the foveola and the thickness of the individual concentric rings were calculated. Sensitivity and specificity of the CSMO diagnosis were established using the average thickness and the thickness of the concentric rings.

It was found that the average thickness of the central macular region was 165.1 µm in the normal subjects and 192.3 µm in eyes without CSMO. The thickness increased significantly to 198.2 µm in eyes with foveal CSMO and 236.9 µm in eyes with diffuse CSMO. Sensitivity for focal CSMO was 48% with average thickness measurements and 83.6% with concentric rings. The corresponding values for detection of diffuse CSMO were 91.7% and 96.1%, respectively. Specificity was 77.4% with average thickness measurements and 79.7% with concentric rings.

Knudsen concluded that, although thickness measurements can be used to distinguish between eyes with and without diffuse CSMO, it is not as effective at distinguishing between eyes with and without foveal CSMO. He added that sub–analysis based on concentric rings around the foveola does seem to be a useful clinical tool for increasing diagnostic certainty.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Sunita Radhakrishnan, MD, an associate at the Glaucoma Center of San Francisco, speaks at the annual Glaucoma 360 meeting about electrical neurostimulation.
3 experts are featured in this series.
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.